IL-18 Production from the NLRP1 Inflammasome Prevents Obesity and Metabolic Syndrome

Cell Metabolism

Volumn 23, Issue 1, 2016, Pages 155-164

  Murphy, Andrew J ^a,b   Kraakman, Michael J ^a   Kammoun, Helene L ^a   Dragoljevic, Dragana ^a,b   Lee, Man K S ^a,b   Lawlor, Kate E ^c,e   Wentworth, John M ^d,e   Vasanthakumar, Ajithkumar ^c,e   Gerlic, Motti ^f   Whitehead, Lachlan W ^d   Dirago, Ladina ^d   Cengia, Louise ^d   Lane, Rachael M ^d   Metcalf, Donald ^d,e   Vince, James E ^c,e   Harrison, Leonard C ^d,e   Kallies, Axel ^c,e   Kile, Benjamin T ^d,e   Croker, Ben A ^g   Febbraio, Mark A ^a,h   Masters, Seth L ^c,e   more..

^a BAKER IDI HEART AND DIABETES INSTITUTE   (Australia)

^b MONASH UNIVERSITY   (Australia)

^c Institute of Medical Research   (Australia)

^d WALTER AND ELIZA HALL INSTITUTE OF MEDICAL RESEARCH   (Australia)

^e UNIVERSITY OF MELBOURNE   (Australia)

^f TEL AVIV UNIVERSITY   (Israel)

^g BOSTON CHILDREN S HOSPITAL   (United States)

^h GARVAN INSTITUTE OF MEDICAL RESEARCH   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

INFLAMMASOME; INTERLEUKIN 1 RECEPTOR; INTERLEUKIN 18; NLRP1 PROTEIN; UNCLASSIFIED DRUG; APOPTOSIS REGULATORY PROTEIN; NALP1 PROTEIN, MOUSE; SIGNAL TRANSDUCING ADAPTOR PROTEIN;

ADIPOSE TISSUE; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CACHEXIA; CONTROLLED STUDY; CYTOKINE PRODUCTION; LIPID DIET; METABOLIC SYNDROME X; MOUSE; NONHUMAN; OBESITY; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; PROTEIN EXPRESSION; PROTEIN FUNCTION; STEATOSIS; ADVERSE EFFECTS; ANIMAL; BIOSYNTHESIS; BODY WEIGHT; GENETICS; KNOCKOUT MOUSE; LIVER; MALE; METABOLISM; PATHOLOGY;

ADAPTOR PROTEINS, SIGNAL TRANSDUCING; ANIMALS; APOPTOSIS REGULATORY PROTEINS; BODY WEIGHT; DIET, HIGH-FAT; INFLAMMASOMES; INTERLEUKIN-18; LIVER; MALE; METABOLIC SYNDROME X; MICE, KNOCKOUT; OBESITY;

EID: 84955295531     PISSN: 15504131     EISSN: 19327420     Source Type: Journal    
DOI: 10.1016/j.cmet.2015.09.024     Document Type: Article

References (30)

1. E.D. Boyden, and W.F. Dietrich Nalp1b controls mouse macrophage susceptibility to anthrax lethal toxin Nat. Genet. 38 2006 240 244
2. K. Esposito, A. Pontillo, M. Ciotola, C. Di Palo, E. Grella, G. Nicoletti, and D. Giugliano Weight loss reduces interleukin-18 levels in obese women J. Clin. Endocrinol. Metab. 87 2002 3864 3866
3. K. Esposito, F. Nappo, F. Giugliano, C. Di Palo, M. Ciotola, M. Barbieri, G. Paolisso, and D. Giugliano Meal modulation of circulating interleukin 18 and adiponectin concentrations in healthy subjects and in patients with type 2 diabetes mellitus Am. J. Clin. Nutr. 78 2003 1135 1140
4. J.N. Fain, D.S. Tichansky, and A.K. Madan Most of the interleukin 1 receptor antagonist, cathepsin S, macrophage migration inhibitory factor, nerve growth factor, and interleukin 18 release by explants of human adipose tissue is by the non-fat cells, not by the adipocytes Metabolism 55 2006 1113 1121
5. M.A. Febbraio Role of interleukins in obesity: implications for metabolic disease Trends Endocrinol. Metab. 25 2014 312 319
6. C.P. Fischer, L.B. Perstrup, A. Berntsen, P. Eskildsen, and B.K. Pedersen Elevated plasma interleukin-18 is a marker of insulin-resistance in type 2 diabetic and non-diabetic humans Clin. Immunol. 117 2005 152 160
7. G. Gorfu, K.M. Cirelli, M.B. Melo, K. Mayer-Barber, D. Crown, B.H. Koller, S. Masters, A. Sher, S.H. Leppla, M. Moayeri, and et al. Dual role for inflammasome sensors NLRP1 and NLRP3 in murine resistance to Toxoplasma gondii MBio 5 2014 e01117-e01113
8. J. Henao-Mejia, E. Elinav, C. Jin, L. Hao, W.Z. Mehal, T. Strowig, C.A. Thaiss, A.L. Kau, S.C. Eisenbarth, M.J. Jurczak, and et al. Inflammasome-mediated dysbiosis regulates progression of NAFLD and obesity Nature 482 2012 179 185
9. J. Hung, B.M. McQuillan, C.M. Chapman, P.L. Thompson, and J.P. Beilby Elevated interleukin-18 levels are associated with the metabolic syndrome independent of obesity and insulin resistance Arterioscler. Thromb. Vasc. Biol. 25 2005 1268 1273
10. P. Jitprasertwong, K.M. Jaedicke, C.J. Nile, P.M. Preshaw, and J.J. Taylor Leptin enhances the secretion of interleukin (IL)-18, but not IL-1β, from human monocytes via activation of caspase-1 Cytokine 65 2014 222 230
11. D.E. Kelley, and B.H. Goodpaster Skeletal muscle triglyceride. An aspect of regional adiposity and insulin resistance Diabetes Care 24 2001 933 941
12. M.J. Kraakman, H.L. Kammoun, T.L. Allen, V. Deswaerte, D.C. Henstridge, E. Estevez, V.B. Matthews, B. Neill, D.A. White, A.J. Murphy, and et al. Blocking IL-6 trans-signaling prevents high-fat diet-induced adipose tissue macrophage recruitment but does not improve insulin resistance Cell Metab. 21 2015 403 416
13. M. Labow, D. Shuster, M. Zetterstrom, P. Nunes, R. Terry, E.B. Cullinan, T. Bartfai, C. Solorzano, L.L. Moldawer, R. Chizzonite, and K.W. McIntyre Absence of IL-1 signaling and reduced inflammatory response in IL-1 type I receptor-deficient mice J. Immunol. 159 1997 2452 2461
14. K.C. Liao, and J. Mogridge Activation of the Nlrp1b inflammasome by reduction of cytosolic ATP Infect. Immun. 81 2013 570 579
15. B. Lindegaard, V.B. Matthews, C. Brandt, P. Hojman, T.L. Allen, E. Estevez, M.J. Watt, C.R. Bruce, O.H. Mortensen, S. Syberg, and et al. Interleukin-18 activates skeletal muscle AMPK and reduces weight gain and insulin resistance in mice Diabetes 62 2013 3064 3074
16. S.L. Masters, M. Gerlic, D. Metcalf, S. Preston, M. Pellegrini, J.A. O'Donnell, K. McArthur, T.M. Baldwin, S. Chevrier, C.J. Nowell, and et al. NLRP1 inflammasome activation induces pyroptosis of hematopoietic progenitor cells Immunity 37 2012 1009 1023
17. M.G. Myers Jr., R.L. Leibel, R.J. Seeley, and M.W. Schwartz Obesity and leptin resistance: distinguishing cause from effect Trends Endocrinol. Metab. 21 2010 643 651
18. M.G. Netea, L.A. Joosten, E. Lewis, D.R. Jensen, P.J. Voshol, B.J. Kullberg, C.J. Tack, H. van Krieken, S.H. Kim, A.F. Stalenhoef, and et al. Deficiency of interleukin-18 in mice leads to hyperphagia, obesity and insulin resistance Nat. Med. 12 2006 650 656
19. G.H. Schernthaner, H.P. Kopp, S. Kriwanek, K. Krzyzanowska, M. Satler, R. Koppensteiner, and G. Schernthaner Effect of massive weight loss induced by bariatric surgery on serum levels of interleukin-18 and monocyte-chemoattractant-protein-1 in morbid obesity Obes. Surg. 16 2006 709 715
20. S. Sun, S. Xia, Y. Ji, S. Kersten, and L. Qi The ATP-P2X7 signaling axis is dispensable for obesity-associated inflammasome activation in adipose tissue Diabetes 61 2012 1471 1478
21. N. Tajik, S.A. Keshavarz, F. Masoudkabir, M. Djalali, H.H. Sadrzadeh-Yeganeh, M.R. Eshraghian, M. Chamary, Z. Ahmadivand, T. Yazdani, and M.H. Javanbakht Effect of diet-induced weight loss on inflammatory cytokines in obese women J. Endocrinol. Invest. 36 2013 211 215
22. K. Takeda, H. Tsutsui, T. Yoshimoto, O. Adachi, N. Yoshida, T. Kishimoto, H. Okamura, K. Nakanishi, and S. Akira Defective NK cell activity and Th1 response in IL-18-deficient mice Immunity 8 1998 383 390
23. M. Trøseid, H. Arnesen, E.M. Hjerkinn, and I. Seljeflot Serum levels of interleukin-18 are reduced by diet and n-3 fatty acid intervention in elderly high-risk men Metabolism 58 2009 1543 1549
24. B. Vandanmagsar, Y.H. Youm, A. Ravussin, J.E. Galgani, K. Stadler, R.L. Mynatt, E. Ravussin, J.M. Stephens, and V.D. Dixit The NLRP3 inflammasome instigates obesity-induced inflammation and insulin resistance Nat. Med. 17 2011 179 188
25. N. Vilarrasa, J. Vendrell, R. Sánchez-Santos, M. Broch, A. Megia, C. Masdevall, N. Gomez, J. Soler, J. Pujol, C. Bettónica, and et al. Effect of weight loss induced by gastric bypass on proinflammatory interleukin-18, soluble tumour necrosis factor-alpha receptors, C-reactive protein and adiponectin in morbidly obese patients Clin. Endocrinol. (Oxf.) 67 2007 679 686
26. H. Wen, D. Gris, Y. Lei, S. Jha, L. Zhang, M.T. Huang, W.J. Brickey, and J.P. Ting Fatty acid-induced NLRP3-ASC inflammasome activation interferes with insulin signaling Nat. Immunol. 12 2011 408 415
27. C. Westwell-Roper, A. Dunne, M.L. Kim, C.B. Verchere, and S.L. Masters Activating the NLRP3 inflammasome using the amyloidogenic peptide IAPP Methods Mol. Biol. 1040 2013 9 18
28. W.H. Witola, E. Mui, A. Hargrave, S. Liu, M. Hypolite, A. Montpetit, P. Cavailles, C. Bisanz, M.F. Cesbron-Delauw, G.J. Fournié, and R. McLeod NALP1 influences susceptibility to human congenital toxoplasmosis, proinflammatory cytokine response, and fate of Toxoplasma gondii-infected monocytic cells Infect. Immun. 79 2011 756 766
29. G.R. Zilverschoon, C.J. Tack, L.A. Joosten, B.J. Kullberg, J.W. van der Meer, and M.G. Netea Interleukin-18 resistance in patients with obesity and type 2 diabetes mellitus Int. J. Obes. 32 2008 1407 1414
30. E.P. Zorrilla, M. Sanchez-Alavez, S. Sugama, M. Brennan, R. Fernandez, T. Bartfai, and B. Conti Interleukin-18 controls energy homeostasis by suppressing appetite and feed efficiency Proc. Natl. Acad. Sci. USA 104 2007 11097 11102